Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his take on choosing molecular tests for treatment for newly diagnosed Colorectal Cancer patients at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.